Published in Proc Natl Acad Sci U S A on July 01, 1977
Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell (2009) 3.61
Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmacol (1980) 2.54
Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc Natl Acad Sci U S A (1979) 2.47
Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proc Natl Acad Sci U S A (1978) 1.98
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci U S A (1999) 1.68
Responsiveness of rat substantia gelatinosa neurones to mechanical but not thermal stimuli revealed by in vivo patch-clamp recording. J Physiol (1999) 1.38
Immunoreactive dynorphin in pituitary and brain. Proc Natl Acad Sci U S A (1980) 1.33
Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation. Proc Natl Acad Sci U S A (1991) 1.23
Collateralized dorsal raphe nucleus projections: a mechanism for the integration of diverse functions during stress. J Chem Neuroanat (2011) 1.14
Naloxone modulates the perception of itch in man. Br J Clin Pharmacol (1980) 1.07
In vitro autoradiography of opiate receptors in rat brain suggests loci of "opiatergic" pathways. Proc Natl Acad Sci U S A (1980) 1.05
Pharmacological properties of a C-fibre response evoked by saphenous nerve stimulation in an isolated spinal cord-nerve preparation of the newborn rat. Br J Pharmacol (1989) 1.05
Proenkephalin mRNA in rat heart. Proc Natl Acad Sci U S A (1986) 1.05
Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A (1981) 1.03
Relative activities of substance P-related peptides in the guinea-pig ileum and rat parotid gland, in vitro. Br J Pharmacol (1982) 0.96
Enkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization study. J Comp Neurol (2009) 0.96
Spinal neurons exhibiting a specific nociceptive response receive abundant substance P-containing synaptic contacts. Proc Natl Acad Sci U S A (1992) 0.95
Analgesic activity of the naturally occurring heptapeptide [Met]enkephalin-Arg6-Phe7. Proc Natl Acad Sci U S A (1980) 0.93
Enkephalin-containing amacrine cells in the avian retina: immunohistochemical localization. Proc Natl Acad Sci U S A (1979) 0.93
Neurotransmitters in the spinal cord dorsal horn in a model of painful neuropathy and in nerve crush. Acta Neuropathol (1995) 0.93
Substance P-driven feed-forward inhibitory activity in the mammalian spinal cord. Mol Pain (2005) 0.90
Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc Natl Acad Sci U S A (1991) 0.88
Rapid preconcentration for liquid chromatography-mass spectrometry assay of trace level neuropeptides. J Am Soc Mass Spectrom (2013) 0.82
Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat. J Physiol (1987) 0.82
Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat. Br J Pharmacol (1990) 0.81
The antinociceptive effect of milnacipran in the monosodium iodoacetate model of osteoarthritis pain and its relation to changes in descending inhibition. J Pharmacol Exp Ther (2013) 0.81
Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord. Proc Natl Acad Sci U S A (1986) 0.81
Neuropeptides and monoaminergic neurotransmitters: their relation to pain. J R Soc Med (1980) 0.78
Localization of immunoreactive dynorphin in neurons cultured from spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A (1982) 0.78
The role of substance P in simultaneously mediating oral pain and inflammation. Anesth Prog (1981) 0.77
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews. Cancer Chemother Pharmacol (2014) 0.77
beta-Endorphin: characteristics of binding sites in rabbit spinal cord. Proc Natl Acad Sci U S A (1980) 0.76
Delta-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones. Br J Pharmacol (1989) 0.76
Post-tetanic depression of spinal reflexes in the rabbit and the possible involvement of opioid peptides. J Physiol (1984) 0.76
The human cuneate nucleus contains discrete subregions whose neurochemical features match those of the relay nuclei for nociceptive information. Brain Struct Funct (2013) 0.75
Calcium requirements for electrically-induced release of an endogenous opiate receptor ligand from the guinea-pig ileum. Br J Pharmacol (1979) 0.75
Ultrastructural analysis of rat ventrolateral periaqueductal gray projections to the A5 cell group. Neuroscience (2012) 0.75
Changes in the disposition of substance P in the rostral ventromedial medulla after inflammatory injury in the rat. Neuroscience (2016) 0.75
Immunohistochemical quantification of substance P in spinal dorsal horns of patients with multiple system atrophy. J Neurol Neurosurg Psychiatry (1991) 0.75
Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (1975) 10.33
Fluorescent antibody methods. Gen Cytochem Methods (1958) 5.56
An unidentified depressor substance in certain tissue extracts. J Physiol (1931) 5.19
Immunohistochemical studies using antibodies to leucine-enkephalin: initial observations on the nervous system of the rat. Neuroscience (1976) 2.56
Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science (1969) 2.40
Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science (1976) 2.35
Substance p: localization in the central nervous system and in some primary sensory neurons. Science (1975) 2.33
Spinal neurons specifically excited by noxious or thermal stimuli: marginal zone of the dorsal horn. J Neurophysiol (1970) 2.26
Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system. Proc Natl Acad Sci U S A (1977) 2.07
Amino-acid sequence of substance P. Nat New Biol (1971) 1.96
Analgesia induced in vivo by central administration of enkephalin in rat. Nature (1976) 1.96
Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience (1976) 1.92
Effects of substance P on functionally identified units in cat spinal cord. Brain Res (1976) 1.90
Analgesia from electrical stimulation in the brainstem of the rat. Science (1971) 1.81
Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res (1976) 1.76
Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. II. Hindbrain (mesencephalon, rhombencephalon). J Comp Neurol (1974) 1.73
Central nervous system mechanisms of analgesia. Pain (1976) 1.69
Evidence for analgesic activity of enkephalin in the mouse. Nature (1976) 1.59
The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). J Pharmacol Exp Ther (1967) 1.59
Opiate and stimulus-produced analgesia: functional anatomy of a medullospinal pathway. Proc Natl Acad Sci U S A (1976) 1.43
Sites of morphine induced analgesia in the primate brain: relation to pain pathways. Brain Res (1974) 1.37
Analgesia from electrical stimulation of the periaqueductal gray matter in the cat: behavioral observations and inhibitory effects on spinal cord interneurons. Brain Res (1973) 1.35
The effects of substance P and other peptides on spinal neurons of the frog. Brain Res (1974) 1.33
Regional distribution of substance P in the spinal cord and nerve roots of the cat and the effect of dorsal root section. Brain Res (1975) 1.33
Morphine analgesia: blockade by raphe magnus lesions. Brain Res (1975) 1.29
Substance P and analgesia. Nature (1976) 1.27
Presence of substance P-like immunoreactivity in plasma from man and dog. Acta Physiol Scand (1975) 1.13
Behavioral and electrophysiological evidence of pain inhibition from midbrain stimulation in the cat. Exp Brain Res (1974) 1.08
Reversal of morphine and stimulus-produced analgesia by subtotal spinal cord lesions. Pain (1977) 1.05
Naloxone reversal of analgesia produced by brain stimulation in the human. Pain (1976) 1.03
Antagonism of stimulation-produced analgesia by p-CPA, a serotonin synthesis inhibitor. Brain Res (1972) 0.98
Suppression by LSD of the inhibitory effect exerted by dorsal raphe stimulation on certain spinal cord interneurons in the cat. Brain Res (1973) 0.98
Neuroanatomical substrates of nociception in the spinal cord. Pain (1975) 0.97
[Comparison in the rat between analgesia induced by stimulation of periacqueducal gray matter and morphine analgesia]. C R Acad Sci Hebd Seances Acad Sci D (1972) 0.94
New long latency bulbospinal evoked potentials blocked by serotonin antagonists. Brain Res (1974) 0.94
Analgesia induced by electrical stimulation of the inferior centralis nucleus of the raphe in the cat. Pain (1975) 0.91
Electro-acupunture and endogenous morphines. Lancet (1976) 0.91
Pain threshold alterations by brain stimulation in the monkey. J Neurosurg (1971) 0.88
Causalgia treated by selective large fibre stimulation of peripheral nerve. Brain (1972) 0.86
Stimulation-produced analgesia: development of tolerance and cross-tolerance to morphine. Science (1975) 0.86
Analgesia produced by brain stimulation: evidence of a prolonged onset period. Exp Neurol (1974) 0.81
Electro-acupuncture. Effect on pain threshold measured with electrical stimulation of teeth. Brain Res (1973) 0.81
Design, synthesis, and evaluation of Phe-Gly mimetics: heterocyclic building blocks for pseudopeptides. J Med Chem (1999) 9.39
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A (1998) 4.14
Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol (1973) 3.54
Peptidergic neurones. Nature (1980) 3.36
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Increased cerebrospinal fluid levels of endorphins after electro-acupuncture. Acta Physiol Scand (1977) 3.15
Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci (1999) 3.10
Growth-rate dependent regulation of mRNA stability in Escherichia coli. Nature (1984) 3.06
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A (2000) 3.04
Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem (1996) 2.93
The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci U S A (1998) 2.91
Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A (2000) 2.87
The stability of E. coli gene transcripts is dependent on determinants localized to specific mRNA segments. Cell (1986) 2.79
Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res (1975) 2.72
Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci (1995) 2.62
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol (1969) 2.61
Immunohistochemical studies using antibodies to leucine-enkephalin: initial observations on the nervous system of the rat. Neuroscience (1976) 2.56
Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study. Eur Heart J (2001) 2.46
A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst (1999) 2.36
Substance p: localization in the central nervous system and in some primary sensory neurons. Science (1975) 2.33
Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature (1997) 2.29
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol (1969) 2.26
Effect of premature termination of translation on mRNA stability depends on the site of ribosome release. Proc Natl Acad Sci U S A (1987) 2.24
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry (1992) 2.15
A molecular model of Alzheimer amyloid beta-peptide fibril formation. J Biol Chem (1999) 2.12
Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol (1967) 2.08
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Ingestion and survival of Y. pseudotuberculosis in HeLa cells. Can J Microbiol (1975) 2.07
Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res (1984) 2.05
Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. Acta Pharmacol Toxicol (Copenh) (1973) 2.03
Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience (1978) 2.01
Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci U S A (1980) 2.00
Distribution of substance P-like immunoreactivity in the central nervous system of the rat--I. Cell bodies and nerve terminals. Neuroscience (1978) 1.99
Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol (1985) 1.97
Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology (1997) 1.96
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons in the rat. Neuroscience (1976) 1.92
Neurochemical basis of acupuncture analgesia. Annu Rev Pharmacol Toxicol (1982) 1.91
High nitric oxide production in human paranasal sinuses. Nat Med (1995) 1.90
Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol (1998) 1.87
Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci U S A (1996) 1.86
P2X3 is expressed by DRG neurons that terminate in inner lamina II. Eur J Neurosci (1998) 1.85
Climate change and the integrity of science. Science (2010) 1.80
Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain (1991) 1.79
p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc Natl Acad Sci U S A (1994) 1.74
Flare and itch induced by substance P in human skin. J Invest Dermatol (1978) 1.72
Localization of substance P-like immunoreactivity in mouse gut. Histochemistry (1975) 1.71
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett (1983) 1.68
Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience (1978) 1.67
Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J (2001) 1.66
A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett (1984) 1.63
Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol (1997) 1.62
Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol Toxicol (Copenh) (1973) 1.56
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron (1995) 1.56
On the occurrence of substance P-containing fibers in sympathetic ganglia: immunohistochemical evidence. Brain Res (1977) 1.55
Expression of the vesicular glutamate transporters-1 and -2 in adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury. Neuroscience (2007) 1.51
Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides (1984) 1.51
Calculation of the electromyographic jitter. J Neurol Neurosurg Psychiatry (1974) 1.49
Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes. Neurosci Lett (1986) 1.49
In vitro studies on central and peripheral monoamine neurons at the ultrastructural level. Z Zellforsch Mikrosk Anat (1968) 1.48
Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol (1986) 1.46
Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukaemia inversely correlates with progression of disease. Br J Haematol (1996) 1.45
Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat. Cell Tissue Res (1991) 1.44
Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic noradrenergic neurons. Proc Natl Acad Sci U S A (1977) 1.44
Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol (1998) 1.44
Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci U S A (1997) 1.44
Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci (1986) 1.43
Controlling amyloid beta-peptide fibril formation with protease-stable ligands. J Biol Chem (1997) 1.43
Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol Scand (1978) 1.42
Autoimmune thyroid dysfunction in the postpartum period. J Clin Endocrinol Metab (1984) 1.41
Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41
Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides (1987) 1.41
Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience (1984) 1.41
Immunohistochemical evidence for the localization of somatostatin--like immunoreactivity in a cell population of the pancreatic islets. Med Biol (1974) 1.40
Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J Neurosci (1998) 1.40